Combination Therapy With Charged Particles and Molecular Targeting: A Promising Avenue to Overcome Radioresistance
نویسندگان
چکیده
منابع مشابه
Targeting NF-kappaB: a promising molecular therapy in inflammatory arthritis.
The nuclear factor-kappa B family of transcription factors is intimately involved in the regulation of the inflammatory responses that play a fundamental role in the damage of articular tissues. Thus, many studies have examined the important contributions of components of the NF-kappaB signaling pathways to the pathogenesis of various rheumatic diseases and their pharmacologic modulation. Curre...
متن کاملa comparison of teachers and supervisors, with respect to teacher efficacy and reflection
supervisors play an undeniable role in training teachers, before starting their professional experience by preparing them, at the initial years of their teaching by checking their work within the proper framework, and later on during their teaching by assessing their progress. but surprisingly, exploring their attributes, professional demands, and qualifications has remained a neglected theme i...
15 صفحه اولTumor Therapy with Heavy Charged Particles
The inverse depth dose profile i.e. the increase of the dose with penetration depth make heavy charged particles like protons and heavy ions an ideal tool for the radiotherapy of deep-seated tumors. For carbon ions this good dose profile is potentiated by an additional increase in the relative biological effectiveness (RBE) towards the end of the particle range. The physical and biological basi...
متن کاملEpigenetic mechanisms in migraine: a promising avenue?
Migraine is a disabling common brain disorder typically characterized by attacks of severe headache and associated with autonomic and neurological symptoms. Its etiology is far from resolved. This review will focus on evidence that epigenetic mechanisms play an important role in disease etiology. Epigenetics comprise both DNA methylation and post-translational modifications of the tails of hist...
متن کاملTargeting EGFR and IGF 1R: a promising combination therapy for metastatic cancer.
Acute drug resistance, intolerable side effects and non-specific target activation are the crucial barriers for efficient translational outcome of target directed cancer drug discovery. In the last five years, many of the bull's eye drugs failed to obtain FDA approval because of highly complicated mechanisms of the targeting receptors. These receptors include epidermal growth factor receptor (E...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Frontiers in Oncology
سال: 2020
ISSN: 2234-943X
DOI: 10.3389/fonc.2020.00128